Mark Winters
Overview
Explore the profile of Mark Winters including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
18
Citations
522
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Sklan E, Staschke K, Oakes T, Elazar M, Winters M, Aroeti B, et al.
J Virol
. 2007 Aug;
81(20):11096-105.
PMID: 17686842
Hepatitis C virus (HCV) is an important cause of liver disease worldwide. Current therapies are inadequate for most patients. Using a two-hybrid screen, we isolated a novel cellular binding partner...
12.
Liu Z, Winters M, Holodniy M, Dai H
Angew Chem Int Ed Engl
. 2007 Feb;
46(12):2023-7.
PMID: 17290476
No abstract available.
13.
Henry K, Katzenstein D, Cherng D, Valdez H, Powderly W, Vargas M, et al.
J Acquir Immune Defic Syndr
. 2006 Jun;
42(2):140-8.
PMID: 16760795
Background: Although an intermittent antiviral treatment (ART) strategy may limit long-term toxicity and cost, there is concern about the risk for virologic failure, selection of drug resistance mutations, and disease...
14.
Kagan R, Winters M, Merigan T, Heseltine P
AIDS Res Hum Retroviruses
. 2004 Mar;
20(1):1-9.
PMID: 15000693
We established a database of HIV-1 reverse transcriptase (RT) and protease (PR) sequences and mutations to monitor the prevalence of antiretroviral drug resistance and mutational patterns in clinical samples submitted...
15.
Shulman N, Winters M
Curr Drug Targets Infect Disord
. 2004 Feb;
3(4):273-81.
PMID: 14754429
The nucleoside reverse transcriptase inhibitors (NRTIs) were the first class of agents used for the treatment of HIV and remain an important component of combination antiretroviral therapy. Resistance to the...
16.
Rasmussen L, Geissler A, Winters M
J Infect Dis
. 2003 Feb;
187(5):809-19.
PMID: 12599055
Human cytomegalovirus isolates were analyzed, both by restriction fragment-length polymorphism typing and by sequencing for intra- and intergenic variability at 9 sites on the genome, to determine whether genetic variation...
17.
Rasmussen L, Geissler A, Cowan C, Chase A, Winters M
J Virol
. 2002 Oct;
76(21):10841-8.
PMID: 12368327
The UL74 (glycoprotein O [gO])-UL75 (gH)-UL115 (gL) complex of human cytomegalovirus (CMV), known as the gCIII complex, is likely to play an important role in the life cycle of the...
18.
Qari S, Winters M, Vandamme A, Merigan T, Heneine W
Antivir Ther
. 2002 Sep;
7(2):131-9.
PMID: 12212925
Zidovudine and other nucleoside analogue reverse transcriptase inhibitors (NRTIs), like zalcitabine and didanosine used for treatment of individuals infected with HIV-1, can select for viruses with Q151M and other associated...